Assesment of the patients with broncopulmonary dysplasia BPD in terms of somatic growth pulmonary problems and neurodevelopmental features on long term follow up Original Article
Bronkopulmoner displazili hastalarımızın uzun dönem izleminde somatik büyüme akciğer sorunları ve nörogelişimsel özelliklerinin irdelenmesi Orijinal Araştırma
Aim: This study has been performed for the assessment of postneonatal problems growth and neuromotor development of the patients with bronchopulmonary displasia BPD Material and Method: 31 of the 39 live preterms 79 who were born in 2003 2004 period were assessed in July 2006 Patients who were diagnosed as BPD were named Group I The control group was formed as preterms who were born in our hospital after Group I patients who were close to Group I in terms of weight and gestational age and who had no history of mechanical ventilation support and was named as Group II The data of the Group II patients were obtained from the computer database and personal files Both groups were assessed for their somatic growth and neurodevelopmental profiles at 21 42 months Results: 20 patients 64 5 from the Group I had at least one respiratory infection and 6 of them were admitted to the hospital Microcephaly was found in 38 7 of our patients and 35 were diagnosed as somatic growth retardation on growth follow up Denver Developmental Screening Test II was found abnormal in 10 32 preterms and 10 32 patients had deficiency and 3 patients had deficiency plus sequel in modified Amiel Tison Test One patient had total blindness 5 patients 16 from the Group II were on therapy for multiple respiratory infections and one of them was diagnosed as reactive airway disease 10 of the patients had somatic growth retardation 13 had microcephaly when Group II patients were assessed in terms of somatic growth Two patients 6 had abnormal Denver II Test 4 patients 16 had deficiency in Modified Amiel Tison Test but none of them had sequel Conclusions: Presence of BPD is a significant risk factor for disease during the somatic and neurodevelopmental follow up As a result of our study we have seen that patients with BPD when compared to control group were significantly retarded in terms of neurological and somatic growth Immaturity intraventricular haemorrage microcephaly meningitis were important risk factors playing role in the morbidity Turk Arch Ped 2008; 43: 17 23 Key words: BPD neurodevelopmental follow up preterm somatic growth
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Aim: This study has been performed for the assessment of postneonatal problems growth and neuromotor development of the patients with bronchopulmonary displasia BPD Material and Method: 31 of the 39 live preterms 79 who were born in 2003 2004 period were assessed in July 2006 Patients who were diagnosed as BPD were named Group I The control group was formed as preterms who were born in our hospital after Group I patients who were close to Group I in terms of weight and gestational age and who had no history of mechanical ventilation support and was named as Group II The data of the Group II patients were obtained from the computer database and personal files Both groups were assessed for their somatic growth and neurodevelopmental profiles at 21 42 months Results: 20 patients 64 5 from the Group I had at least one respiratory infection and 6 of them were admitted to the hospital Microcephaly was found in 38 7 of our patients and 35 were diagnosed as somatic growth retardation on growth follow up Denver Developmental Screening Test II was found abnormal in 10 32 preterms and 10 32 patients had deficiency and 3 patients had deficiency plus sequel in modified Amiel Tison Test One patient had total blindness 5 patients 16 from the Group II were on therapy for multiple respiratory infections and one of them was diagnosed as reactive airway disease 10 of the patients had somatic growth retardation 13 had microcephaly when Group II patients were assessed in terms of somatic growth Two patients 6 had abnormal Denver II Test 4 patients 16 had deficiency in Modified Amiel Tison Test but none of them had sequel Conclusions: Presence of BPD is a significant risk factor for disease during the somatic and neurodevelopmental follow up As a result of our study we have seen that patients with BPD when compared to control group were significantly retarded in terms of neurological and somatic growth Immaturity intraventricular haemorrage microcephaly meningitis were important risk factors playing role in the morbidity Turk Arch Ped 2008; 43: 17 23 Key words: BPD neurodevelopmental follow up preterm somatic growth
📊
Key Findings & Data:Aim: This study has been performed for the assessment of postneonatal problems growth and neuromotor development of the patients with bronchopulmonary displasia BPD Material and Method: 31 of the 39 live preterms 79 who were born in 2003 2004 period were assessed in July 2006 Patients who were diagnosed as BPD were named Group I The control group was formed as preterms who were born in our hospital after Group I patients who were close to Group I in terms of weight and gestational age and who had no history of mechanical ventilation support and was named as Group II The data of the Group II patients were obtained from the computer database and personal files Both groups were assessed for their somatic growth and neurodevelopmental profiles at 21 42 months Results: 20 patients 64 5 from the Group I had at least one respiratory infection and 6 of them were admitted to the hospital Microcephaly was found in 38 7 of our patients and 35 were diagnosed as somatic growth retardation on growth follow up Denver Developmental Screening Test II was found abnormal in 10 32 preterms and 10 32 patients had deficiency and 3 patients had deficiency plus sequel in modified Amiel Tison Test One patient had total blindness 5 patients 16 from the Group II were on therapy for multiple respiratory infections and one of them was diagnosed as reactive airway disease 10 of the patients had somatic growth retardation 13 had microcephaly when Group II patients were assessed in terms of somatic growth Two patients 6 had abnormal Denver II Test 4 patients 16 had deficiency in Modified Amiel Tison Test but none of them had sequel Conclusions: Presence of BPD is a significant risk factor for disease during the somatic and neurodevelopmental follow up As a result of our study we have seen that patients with BPD when compared to control group were significantly retarded in terms of neurological and somatic growth Immaturity intraventricular haemorrage microcephaly meningitis were important risk factors playing role in the morbidity Turk Arch Ped 2008; 43: 17 23 Key words: BPD neurodevelopmental follow up preterm somatic growth
💡
Conclusion & Impact:Aim: This study has been performed for the assessment of postneonatal problems growth and neuromotor development of the patients with bronchopulmonary displasia BPD Material and Method: 31 of the 39 live preterms 79 who were born in 2003 2004 period were assessed in July 2006 Patients who were diagnosed as BPD were named Group I The control group was formed as preterms who were born in our hospital after Group I patients who were close to Group I in terms of weight and gestational age and who had no history of mechanical ventilation support and was named as Group II The data of the Group II patients were obtained from the computer database and personal files Both groups were assessed for their somatic growth and neurodevelopmental profiles at 21 42 months Results: 20 patients 64 5 from the Group I had at least one respiratory infection and 6 of them were admitted to the hospital Microcephaly was found in 38 7 of our patients and 35 were diagnosed as somatic growth retardation on growth follow up Denver Developmental Screening Test II was found abnormal in 10 32 preterms and 10 32 patients had deficiency and 3 patients had deficiency plus sequel in modified Amiel Tison Test One patient had total blindness 5 patients 16 from the Group II were on therapy for multiple respiratory infections and one of them was diagnosed as reactive airway disease 10 of the patients had somatic growth retardation 13 had microcephaly when Group II patients were assessed in terms of somatic growth Two patients 6 had abnormal Denver II Test 4 patients 16 had deficiency in Modified Amiel Tison Test but none of them had sequel Conclusions: Presence of BPD is a significant risk factor for disease during the somatic and neurodevelopmental follow up As a result of our study we have seen that patients with BPD when compared to control group were significantly retarded in terms of neurological and somatic growth Immaturity intraventricular haemorrage microcephaly meningitis were important risk factors playing role in the morbidity Turk Arch Ped 2008; 43: 17 23 Key words: BPD neurodevelopmental follow up preterm somatic growth
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Bronkopulmoner displazi · erken doğmuş bebek · nörogelişimsel izlem
Abstract
Aim: This study has been performed for the assessment of postneonatal problems growth and neuromotor development of the patients with bronchopulmonary displasia BPD Material and Method: 31 of the 39 live preterms 79 who were born in 2003 2004 period were assessed in July 2006 Patients who were diagnosed as BPD were named Group I The control group was formed as preterms who were born in our hospital after Group I patients who were close to Group I in terms of weight and gestational age and who had no history of mechanical ventilation support and was named as Group II The data of the Group II patients were obtained from the computer database and personal files Both groups were assessed for their somatic growth and neurodevelopmental profiles at 21 42 months Results: 20 patients 64 5 from the Group I had at least one respiratory infection and 6 of them were admitted to the hospital Microcephaly was found in 38 7 of our patients and 35 were diagnosed as somatic growth retardation on growth follow up Denver Developmental Screening Test II was found abnormal in 10 32 preterms and 10 32 patients had deficiency and 3 patients had deficiency plus sequel in modified Amiel Tison Test One patient had total blindness 5 patients 16 from the Group II were on therapy for multiple respiratory infections and one of them was diagnosed as reactive airway disease 10 of the patients had somatic growth retardation 13 had microcephaly when Group II patients were assessed in terms of somatic growth Two patients 6 had abnormal Denver II Test 4 patients 16 had deficiency in Modified Amiel Tison Test but none of them had sequel Conclusions: Presence of BPD is a significant risk factor for disease during the somatic and neurodevelopmental follow up As a result of our study we have seen that patients with BPD when compared to control group were significantly retarded in terms of neurological and somatic growth Immaturity intraventricular haemorrage microcephaly meningitis were important risk factors playing role in the morbidity Turk Arch Ped 2008; 43: 17 23 Key words: BPD neurodevelopmental follow up preterm somatic growth
Özet
Amaç: Bu çalışma bronkopulmoner displazi’li BPD hastaların yenidoğan dönemi sonrasındaki sorunları büyüme ve nöromotor gelişmelerini değerlendirmek amacıyla yapıldı Gereç ve Yöntem: 2003 2004 tarihleri arasında doğan ve yaşayan 39 olgudan 31’ine 79 ulaşılarak 2006 yılı Temmuz ayında değerlendirildi Bronkopulmoner displazili hastalara Grup I adı verildi Kontrol grubu ise Grup I’deki her bir hastadan sonra hastanemizde doğan en yakın tartı ve gebelik haftasında olan ve hiç mekanik vantilasyon desteği gerekmeyen erken doğmuş bebeklerden oluşturuldu ve Grup II olarak adlandırıldı Grup II’deki hastalara ait bilgiler veri tabanından ve dosyalarından elde edildi 21 42 ayda her iki grubun somatik büyüme ve nörogelişimsel süresi değerlendirildi Bulgular: Grup I’deki hastaların 20’si 64 5 bir veya daha fazla akciğer enfeksiyonu geçirirken altısı bu nedenle hastaneye yatırıldı Büyüme izleminde hastaların 38 7’sinde mikrosefali 35’inde somatik büyüme geriliği bulundu Nörogelişimsel değerlendirmede Denver Gelişimsel Tarama Testi DGTT II 10 32 erken doğmuş bebekte anormal bulunurken Modifiye Amiel Tison’da 10 32 olguda yetersizlik üç olguda sekel yetersizlik bulundu Bir hastada körlük gelişmişti Grup II’de ise hastaların beşi birden fazla akciğer enfeksiyonu nedeniyle tedavi edilirken hastalardan birine reaktif hava yolu hastalığı tanısı kondu Grup II’deki hastaların somatik büyüme özelliklerine bakıldığında; hastaların 10’unda somatik büyüme geriliği 13’ünde mikrosefali bulundu DGTT II iki 6 erken doğmuş bebekte anormal bulunurken Modifiye Amiel Tison’da 4 16 olguda yetersizlik saptandı ancak hiçbirinde sekel gelişmemişti Çıkarımlar: Literatürde somatik ve nörogelişimsel izlemde BPD’nin varlığı önemli bir hastalık nedeni olarak vurgulanmaktadır Biz BPD’li hastalarımızın kontrol grubuyla karşılaştırıldığında hem somatik hem de nörolojik gelişimde önemli derecede geri kaldıklarını gördük İmmatürite kafa içine kanama mikrosefali menenjit sinir sistemine ait hastalıkları arttıran etmenlerdi Türk Ped Arş 2008; 43: 17 23 Anahtar kelimeler: Bronkopulmoner displazi erken doğmuş bebek nörogelişimsel izlem somatik büyüme
Kavuncuoğlu, S., Gök, E. Y., Altuncu, E., Arduç, A., Alpaslan, S., Arslan, G., Aksüyek, E., Öztüregen, E., Çizmeci, M. N. (2008). Assesment of the patients with broncopulmonary dysplasia BPD in terms of somatic growth pulmonary problems and neurodevelopmental features on long term follow up Original Article. Türk Pediatri Arşivi, Cilt: 43 Sayı: 1, 17–23. https://ajindex.com/articles/1011933
Lee SK, McMillan DD, Ohlson A, et al. Variations in practice and outcomes in the Canadian NICU Network: 1996-1997. Pediat- rics 2000; 106:1070- 9 Lemons JA, Bauer CR, Oh W, et al. Very low birth weight out- comes of the National İnstitutes of Child Health and Human De- volopment Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001; 107(1): E1. Sauve RS, Singhal N. Long-term morbidity of infants with bronchopulmonary dysplasia. Pediatrics 1985; 76: 725-33.
Bhutani VK, Abbasi S. Long-term pulmonary consequenses in survivors with bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 649-71.
Bregman J, Farrell EE. Neurodevelopmental outcome in infants with bronchopulmonary dysplasia. Clin Perinatol 1992; 19: 673-94.
Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard score, expanded to include extremely pre- mature infants. J Pediatr 1991; 119:417-23.
Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated, from live births of gestatio- nal ages from 26-42 weeks. Pediatrics 1986; 37: 403-8.
Papile L, Burstein J, Burstein R, Koffler H. İncidence and evo- lution of subependymal and intraventrikular hemorrhage: a study of infants with weights less than 1500 gm. J Pediatr 1978; 92: 529-34.
Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment ba- sed on staging criteria. Ped Clin North Am 1986; 33: 179-201. International Committee for Classification of ROP: An interna- tional classification of retinopathy of prematurity. II. The Classi- fication of retinal detachment. Arch Ophthalmol 1987;105: 906. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Res- pir Crit Care Med 2001; 163: 1723-9. Halliday H. Clinical trials of postnatal corticosteroids: inhaled and systemic. Biol Neonate 1999; 76:29–40.
Halliday HL, Ehrenkranz RA. Delayed (>3weeks) postnatal cor- ticosteroids for chronic lung disease in preterm infants (Coc- hrane Review). Cochrane Database Syst Rev 2001; 2: CD001145. Neyzi O, Binyıldız P, Alp H. Türk çocuklarında büyüme-gelişme normlerı I. Tartı ve boy değerleri. İst Tıp Fak Mec (Suppl) 1978; 41: 74. Denver. Anlar B, Yalaz K. Denver II Gelişimsel Tarama Testi, Türk çocuklarına uyarlanması ve standardizasyonu. HUTF Ped Nöroloji Bilim Dalı Ankara 1995; 1-43.
Ritchie, SK. Primary care of the premature infant discharges from the intensive care unit. Am J. Maternal/Child Nurs 2002; 27: 76-85.
Roth SC, Baudin J, Pezzani-Golds M, Townsend J, Reynolds EO, S